Showing results (31-40 of 51) with videos related to

Sort By:
Pageof 6
Journal of Medicinal Chemistry|June 25, 2013
Synthesis and biological evaluation of metabolites of 2-n-butyl-9-methyl-8-[1,2,3]triazol-2-yl-9H-purin-6-ylamine (ST1535), a potent antagonist of the A2A adenosine receptor for the treatment of Parkinson's diseaseGiovanni Piersanti, Francesca Bartoccini, Simone Lucarini, et al.
European Journal of Pharmacology|May 5, 2015
Animal models of Parkinson׳s disease: Effects of two adenosine A2A receptor antagonists ST4206 and ST3932, metabolites of 2-n-Butyl-9-methyl-8-[1,2,3]triazol-2-yl-9H-purin-6-ylamine (ST1535)Maria Antonietta Stasi, Patrizia Minetti, Katia Lombardo, et al.
European Journal of Pharmacology|May 10, 2011
ST1936 stimulates cAMP, Ca2+, ERK1/2 and Fyn kinase through a full activation of cloned human 5-HT6 receptorsTeresa Riccioni, Fabio Bordi, Patrizia Minetti, et al.
The International Journal of Neuropsychopharmacology|October 11, 2007
ST2472: a new potential antipsychotic with very low liability to induce side-effectsMaria A Stasi, Stefano Di Serio, Mario Vertechy, et al.
The International Journal of Neuropsychopharmacology|July 24, 2002
Region-dependent effects of flibanserin and buspirone on adenylyl cyclase activity in the human brainDonatella Marazziti, Lionella Palego, Annalisa Giromella, et al.
Experimental Neurology|May 7, 2009
A2A adenosine receptor antagonists protect the striatum against rotenone-induced neurotoxicityVincenzo Belcastro, Alessandro Tozzi, Michela Tantucci, et al.
Molecular Immunology|June 19, 2009
Immunogenic, antigenic, fibrillogenic and inflammatory properties of new simplified beta-amyloid peptidesMaria Rossi, Paola Piovesan, Orlando Ghirardi, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 20, 2012
The novel reversible fatty acid amide hydrolase inhibitor ST4070 increases endocannabinoid brain levels and counteracts neuropathic pain in different animal modelsAntonio Caprioli, Roberto Coccurello, Cinzia Rapino, et al.
Journal of Medicinal Chemistry|January 4, 2013
Synthesis of (E)-8-(3-chlorostyryl)caffeine analogues leading to 9-deazaxanthine derivatives as dual A(2A) antagonists/MAO-B inhibitorsSilvia Rivara, Giovanni Piersanti, Francesca Bartoccini, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|February 4, 2011
The distinct role of medium spiny neurons and cholinergic interneurons in the D₂/A₂A receptor interaction in the striatum: implications for Parkinson's diseaseAlessandro Tozzi, Antonio de Iure, Massimiliano Di Filippo, et al.
Pageof 6